About Morcel Biotech Private Limited
Data last updated:
Morcel Biotech Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC320395. Its GSTIN is 07AALCM1880G1ZB (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poonam Pal and Shyam Nandan Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. – V10 Kh. No. 69/2/2 Blk – V Budh Vihar Sharma Colony Phase – II, Delhi, India – 110086.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.07 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹7.23 Lakh (net margin 1.8%) and EBITDA of ₹10.21 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 34% over five years.
As per MCA filings, the company has open charges of ₹55 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website morcelbiotech.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH. No. – V10 Kh. No. 69/2/2 Blk – V Budh Vihar Sharma Colony Phase – II, Delhi, India – 110086
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Morcel Biotech Private Limited
The main business activity of Morcel Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Morcel Biotech Private Limited FY 2025 filings available
Morcel Biotech Private Limited reported revenue of ₹4.07 Cr (down 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Morcel Biotech Private Limited
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 34%. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Morcel Biotech Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹4.07 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.21 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.23 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Morcel Biotech Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Morcel Biotech are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Morcel Biotech Private Limited
Morcel Biotech Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medin Life Pharma Private Limited | ₹4.08 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Thane, Maharashtra, India |
| Queensvial Industries India Private Limited | ₹4.08 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Porur, Chennai, Tamil Nadu, India |
| Chemtotal Labs Private Limited | ₹4.08 Cr (FY 2025) | •••• | •••• | 75.0% | •••• | Jodhpur, Rajasthan, India |
| Antler Life Sciences Private Limited | ₹4.08 Cr (FY 2020) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Biotex Life Solutions Private Limited | ₹4.08 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Morcel Biotech Private Limited this company | ₹4.07 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Delhi, India |
| Ramkrishna Monolithics Private Limited | ₹4.07 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Durgapur, West Bengal, India |
| Raipur Carbonics Private Limited | ₹4.07 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Raipur, Chhattisgarh, India |
| Nomisma Healthcare Private Limited | ₹4.07 Cr (FY 2025) | •••• | •••• | 110.0% | •••• | Vadodara, Gujarat, India |
| Sainex Met Chem Pharma Private Limited | ₹4.07 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Umbergaon, Gujarat, India |
| Noxxon Pharmaceuticals Private Limited | ₹4.07 Cr (FY 2024) | •••• | •••• | 44.0% | •••• | Mohali, Punjab, India |
Peers are the five companies nearest above and the five nearest below Morcel Biotech by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Morcel Biotech Private Limited
Morcel Biotech Private Limited is audited by BSRT & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BSRT & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Morcel Biotech Private Limited
Morcel Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Pal | Director | 10 Jul 2017 | 9 Years 2 Months | Current |
| Shyam Nandan Tiwari | Director | 13 Jun 2024 | 2 Years 3 Months | Current |
Ownership and Shareholding of Morcel Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Morcel Biotech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2023 | Yes Bank Limited | ₹55 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Morcel Biotech Private Limited
Employment history and EPFO contributions of people linked to Morcel Biotech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Morcel Biotech Private Limited
Morcel Biotech Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Rajendra Prasad Nautiyal ceased to be Director on 13 Jun 2024.
Credit Ratings, Litigation & Regulatory Alerts for Morcel Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Morcel Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Morcel Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Morcel Biotech Private Limited
Morcel Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCM1880G1ZB | Delhi | Active | 19 Nov 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Morcel Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Morcel Biotech Private Limited
Morcel Biotech is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 July 2017 (9+ years old) and is registered under CIN U74999DL2017PTC320395.
Morcel Biotech reported revenue of ₹4.07 Cr for FY 2024 (down 21% YoY).
Morcel Biotech has 2 current directors:
- Poonam Pal - Director
- Shyam Nandan Tiwari - Director
Morcel Biotech reported a net profit of ₹7.23 Lakh (net margin 1.8%) and EBITDA of ₹10.21 Lakh (EBITDA margin 2.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Morcel Biotech is 29% over three years and 34% over five years. In the latest year (FY 2024) revenue fell 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Morcel Biotech is 07AALCM1880G1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Morcel Biotech is U74999DL2017PTC320395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Morcel Biotech was incorporated on 10 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Morcel Biotech by revenue are Medin Life Pharma Private Limited, Queensvial Industries India Private Limited, Chemtotal Labs Private Limited, Antler Life Sciences Private Limited, Biotex Life Solutions Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajendra Prasad Nautiyal ceased to be Director on 13 Jun 2024. Shyam Nandan Tiwari was appointed as Director on 13 Jun 2024. Poonam Pal was appointed as Director on 10 Jul 2017.
Morcel Biotech can be reached through the website morcelbiotech.com. Its registered office is in Delhi, India.